What are Some Examples of Biosimilars in Oncology?
Several biosimilars have been approved for use in oncology. Examples include biosimilars for Trastuzumab (used in breast cancer), Bevacizumab (used in colorectal cancer), and Rituximab (used in non-Hodgkin’s lymphoma). These biosimilars undergo stringent regulatory scrutiny to ensure they meet the same standards of efficacy and safety as the originator biologics.